Graylands Hospital Drug Bulletin Emerging Psychoactive Substances - Spotlight on ‘legal-highs’ North Metropolitan Health Service – Mental Health December 2013 Vol 20 No.4 ISSN 1323–1251 Introduction - JWH-073 - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-09-30 04:00:22 Cannabis Designer drug Synthetic cannabis Benzylpiperazine JWH-018 JWH-073 Trifluoromethylphenylpiperazine Tetrahydrocannabinol Methylenedioxypyrovalerone Euphoriants Chemistry Medicine		Graylands Hospital Drug Bulletin Emerging Psychoactive Substances - Spotlight on ‘legal-highs’ North Metropolitan Health Service – Mental Health December 2013 Vol 20 No.4 ISSN 1323–1251 Introduction Add to Reading List Source URL: www.watag.org.au Download Document from Source Website File Size: 236,95 KB Share Document on Facebook

	N-benzylpiperazine (BZP) Pre-Review Report Expert Committee on Drug Dependence Thirty-fifth Meeting Hammamet, Tunisia, 4-8 June 2012 DocID: YDyg - View Document
	Explanatory notes Data reported later than 1 November 2014 could not be taken into consideration in preparing this report. The designations employed and the presentation of the material in this publication do not imply t DocID: VNmt - View Document
	Graylands Hospital Drug Bulletin Emerging Psychoactive Substances - Spotlight on ‘legal-highs’ North Metropolitan Health Service – Mental Health December 2013 Vol 20 No.4 ISSN 1323–1251 Introduction DocID: U6td - View Document
	NEW DRUG: meta-Chlorophenylpiperazine (mCPP) Kevin G. Shanks, [removed] AIT Laboratories 2265 Executive Drive, Indianapolis, IN[removed]chlorophenyl) piperazine, or mCPP, is a piperazine metabolite of the dr DocID: PQCV - View Document
	Microsoft Word - TFMPP Monotgraph-edited.doc DocID: M5P5 - View Document